QA: IMMUCELL CORP DE in us_medicinal_products/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000811641_2022_IMMUCELL_CORP_DE.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000811641, IMMUCELL CORP DE

  xvar xval
0 LiabilitiesNoncurrent 9,354,279
1 LiabilitiesCurrent 2,534,469
2 remainder_Liabilities 0
3 AssetsCurrent 16,264,868
4 AssetsNoncurrent 1,135,248
5 PropertyPlantAndEquipmentNet 26,893,599
6 Goodwill 171,973
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 14,817,066
9 ResearchAndDevelopmentExpense 4,168,518
10 remainder_Expenses 9,165
11 remainder_Revenues 19,242,969
12 remainder_NetIncome -326,512
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 11,888,748
1 Assets 44,465,688
2 Expenses 18,994,749
3 Revenues 19,242,969
4 StockholdersEquity 32,576,940
5 NetIncome -78,292
6 ComprehensiveNetIncome -78,292
7 BaseVar 47,459,333
8 EconomicCapitalRatio 0.980

Edgar->Model Mapping

Feature Distribution

Change over Time